MB-106 - Fortress
Imbruvica (ibrutinib) - AbbVie, J&J
Jaypirca (pirtobrutinib) - Eli Lilly
bendamustine - Generic mfg.
dexamethasone - Generic mfg.
Calquence (acalabrutinib) - AstraZeneca
cyclophosphamide - Generic mfg.
fludarabine IV - Generic mfg.
Actemra IV (tocilizumab) - Roche, JW Pharma
https://library.ehaweb.org/eha/2024/eha2024-congress/419548/brian.till.high.efficacy.and.favorable.safety.of.cd20-targeted.car-t.therapy.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Ace_id%3D2552%2Aot_id%3D29176%2Amarker%3D5101%2Afeatured%3D18527
 
Brian Till; Kelsey Baker; Mary Redman; Sang Yun Lee; Cecilia Yueng; Dong Hoon Lee; Allie Sullivan; David Qian; Xiaoling Song; Bruce Dezube; Aude Chapuis; Damian Green; Ryan Cassaday; Hans-Peter Kiem; Filippo Milano; Folashade Otegbeye; Jordan Gauthier; Alexandre Hirayama; Mary Kwok; Christina Poh; Chaitra Ujjani; Ajay Gopal; David Maloney; Mazyar Shadman
 
May 15, 2024
 
Next